Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. INmune Bio Inc shares valued at $52,868 were purchased by Moss David J on Sep 30 ’24. At $5.29 per share, Moss David J acquired 10,000 shares. The insider’s holdings grew to 1,285,869 shares worth approximately $11.86 million following the completion of this transaction.
Also, Tesi Raymond Joseph purchased 15,380 shares, netting a total of over 98,048 in proceeds. Following the buying of shares at $6.38 each, the insider now holds 1,554,106 shares.
Before that, Moss David J had added 7,690 shares to its account. In a trade valued at $49,024, the Chief Financial Officer bought INmune Bio Inc shares for $6.38 each. Upon closing the transaction, the insider’s holdings increased to 7,690 shares, worth approximately $11.76 million.
As published in their initiating research note from Rodman & Renshaw on January 28, 2025, INmune Bio Inc [INMB] has been a Buy and the price target has been revised to $23. Analysts at Alliance Global Partners started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of September 27, 2024, Raymond James has initiated its “an Outperform” rating for INMB. Earlier on August 22, 2024, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for INMB stock.
Analyzing INMB Stock Performance
During the last five days, there has been a surge of approximately 17.01%. Over the course of the year, INmune Bio Inc shares have jumped approximately 97.43%. Shares of the company reached a 52-week high of $9.90 on 01/30/25 and a 52-week low of $4.73 on 01/02/25. A 50-day SMA is recorded $5.58, while a 200-day SMA reached $7.16. Nevertheless, trading volume fell to 0.74 million shares from 0.42 million shares the previous day.
Support And Resistance Levels for INmune Bio Inc (INMB)
According to the 24-hour chart, there is a support level at 8.38, which, if violated, would cause prices to drop to 7.54. In the upper region, resistance lies at 9.98. The next price resistance is at 10.74. RSI (Relative Strength Index) is 76.22 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.47, which suggests the price will increase in the coming days. Percent R is at 14.32%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
